About this Webinar
Respiratory Syncytial Virus- Opportunity Analysis and Forecasts to 2028
Speakers
Michael Breen, PhD
Michael Breen, PhD, is the Director of Infectious Diseases and Ophthalmology at GlobalData in Boston. He has over eight years of experience in market analysis, business intelligence, and providing strategic insight for the pharmaceutical industry. Prior to his current role, he was a Senior Analyst for Decision Resources Group, where he gained extensive experience writing in-depth reports and developing forecasts for a variety of indications, including rare and infectious diseases and vaccines.
Michael has a BA in biology and biochemistry from Hunter College, and a PhD in biochemistry from Boston University School of Medicine
Paul Jeng, PhD
Paul Jeng, PhD is a Senior Infectious Disease Analyst at GlobalData in Boston. Prior to GlobalData, Paul worked as a research fellow at the Memorial Sloan Kettering Cancer Center, where he managed an industry-academic drug discovery collaboration focused on targeting oncoproteins with small molecules for cancer therapy. Paul graduated from Brown University with a BSc with Honors in Biology and Molecular Pharmacology, and received a PhD in Pharmacology from Cornell University where his research focused on dysregulated cell death pathways in cancer. As a doctoral student, Paul was involved in organizing departmental and institutional events, including serving as the chair for student research symposia and on the leadership team of the graduate student biotechnology club. He also has experience with life sciences consulting and freelance science writing.
Past Webinars
View more past webinarsUpcoming Webinars
View more upcoming webinarsSearch companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Access more premium companies when you subscribe to Explorer


